Unnatural Products, Inc. (UNP), a biotech company pairing AI with chemistry to enable the next generation of molecularly targeted therapeutics, announced a collaboration with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to apply UNP’s technology to design and develop macrocyclic candidates against an oncology therapeutic target.